Skip to the answer

Viloxazine Uses, Dosage, Side Effects and Interactions

Brand name
Qelbree

Qelbree was approved by the FDA in April 2021 as an extended-release capsule. No generic is listed as extended-release capsules.

First generic of Qelbree: our estimate, 2031 to 2032

Viloxazine is a non-stimulant medicine used to treat attention-deficit hyperactivity disorder (ADHD) in adults and children 6 years and older.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 2, 2026 Where our facts come from

Quick links

Ask Anything About ViloxazineType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Viloxazine in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Viloxazine (Qelbree) is a once-daily non-stimulant medicine for ADHD in adults and children 6 and older, thought to work by raising norepinephrine, a brain chemical behind attention, and it is often chosen when stimulants are not a good fit. Most people tolerate it fairly well; sleepiness, tiredness, a smaller appetite and nausea are the common complaints, plus trouble sleeping, especially in adults. It carries a boxed warning for suicidal thoughts and behavior, so watch closely for new or sudden mood changes, especially in the first few months and after any dose change. Have blood pressure, heart rate and weight checked before and during treatment.

Key Takeaways From the HelloPharmacist Team

  • If swallowing is hard, sprinkle all the contents on pudding (eat within 15 minutes) or applesauce (within 2 hours), unchewed.
  • It strongly blocks a liver enzyme (CYP1A2), so tizanidine, theophylline, duloxetine, ramelteon, tasimelteon and alosetron cannot be taken with it.
  • Never combine it with an MAOI antidepressant or within 14 days of stopping one; blood pressure can spike dangerously.
  • Mention any personal or family history of bipolar disorder before starting, since viloxazine can trigger mania (extreme energy, racing thoughts).

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Viloxazine.

Qelbree can increase suicidal thoughts and behavior. In studies, more people with ADHD taking Qelbree had suicidal thoughts or behavior than those taking placebo. This applies to both children and adults.

Patients should be closely monitored for worsening and for new suicidal thoughts or actions, especially early in treatment and when the dose changes. Watch for new or worse depression, anxiety, agitation, irritability, aggression, trouble sleeping or unusual behavior changes. Call your healthcare provider right away if you notice any of these.

Read the full warning on DailyMed →

Viloxazine by the Numbers

Strengths
3
in one form
Makers and packagers
1
Earliest FDA record
2020
Rank by Medicaid prescriptions
#277 of 1,666 drugs
More prescriptions than 83% of the 1,666 drugs we measure
451,086 prescriptions, Q1–Q4 2025

Patient Information Guide for Viloxazine

What It’s Used For

Viloxazine is used for one condition:

  • ADHD in adults and children 6 years and older (Qelbree extended-release capsules, taken by mouth)

How It Works

Viloxazine blocks the norepinephrine transporter, which clears norepinephrine from the space between nerve cells. This is thought to leave more norepinephrine available in the brain. How this helps ADHD is not fully clear.

It also binds to a serotonin receptor called 5-HT2C and partly activates it.

Drug Class

Drug Class

  • Norepinephrine Reuptake Inhibitor
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Norepinephrine Reuptake Inhibitor

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Norepinephrine Uptake Inhibitors
  • Cytochrome P450 2D6 Inhibitors
  • Cytochrome P450 1A2 Inhibitors
  • Cytochrome P450 2B6 Inhibitors
  • Cytochrome P450 3A4 Inhibitors

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Viloxazine in the FDA’s index.

From our Patient Information GuideViloxazine blocks the norepinephrine transporter, which clears norepinephrine from the space between nerve cells. This is thought to leave more norepinephrine available in the brain. How this helps ADHD is not fully clear. Read How Viloxazine Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Viloxazine in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other antidepressants

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Qelbree is taken by mouth once daily, with or without food. Your prescriber adjusts the dose over time based on your response and tolerance.

  • Swallow the capsule whole. Do not cut, crush or chew it.
  • Or sprinkle the whole capsule contents on applesauce or pudding and swallow without chewing, within 2 hours or 15 minutes respectively.
  • Ask your prescriber what to do about a missed dose.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Adults

Starting dose 200 mg once daily Highest dose 600 mg a day
  • Dosage may be titrated in increments of 200 mg weekly, depending on response and tolerability

Good to know

  • Assess heart rate and blood pressure prior to initiating treatment, following increases in dosage, and periodically while on therapy.
  • Administer orally with or without food. Do not cut, crush, or chew the capsules. Swallow capsules whole, or open the capsule and sprinkle the entire contents over a teaspoonful or tablespoonful of pudding or applesauce.

    Consume the food mixture in its entirety, without chewing, within 15 minutes for pudding, or within 2 hours for applesauce; do not store for future use. Pharmacological treatment of ADHD may be needed for extended periods.

    Periodically reevaluate the long-term use and adjust dosage as needed.

Checks and decisions your prescriber makes 1 step

Your prescriber follows these steps. Ask them about any you don’t understand.

  • Screen patients for a personal or family history of suicide, bipolar disorder, and depression prior to initiating treatment.

ADHD stands for attention-deficit hyperactivity disorder.

Children 6 to 11 years old

Starting dose 100 mg once daily Highest dose 400 mg a day
  • Dosage may be titrated in increments of 100 mg at weekly intervals, depending on response and tolerability

Good to know

  • Assess heart rate and blood pressure prior to initiating treatment, following increases in dosage, and periodically while on therapy.
  • Administer orally with or without food. Do not cut, crush, or chew the capsules. Swallow capsules whole, or open the capsule and sprinkle the entire contents over a teaspoonful or tablespoonful of pudding or applesauce.

    Consume the food mixture in its entirety, without chewing, within 15 minutes for pudding, or within 2 hours for applesauce; do not store for future use. Pharmacological treatment of ADHD may be needed for extended periods.

    Periodically reevaluate the long-term use and adjust dosage as needed.

Checks and decisions your prescriber makes 1 step

Your prescriber follows these steps. Ask them about any you don’t understand.

  • Screen patients for a personal or family history of suicide, bipolar disorder, and depression prior to initiating treatment.

ADHD stands for attention-deficit hyperactivity disorder.

Children 12 to 17 years old

Starting dose 200 mg once daily Highest dose 400 mg a day
  • After 1 week, dosage may be titrated by an increment of 200 mg, depending on response and tolerability

Good to know

  • Assess heart rate and blood pressure prior to initiating treatment, following increases in dosage, and periodically while on therapy.
  • Administer orally with or without food. Do not cut, crush, or chew the capsules. Swallow capsules whole, or open the capsule and sprinkle the entire contents over a teaspoonful or tablespoonful of pudding or applesauce.

    Consume the food mixture in its entirety, without chewing, within 15 minutes for pudding, or within 2 hours for applesauce; do not store for future use. Pharmacological treatment of ADHD may be needed for extended periods.

    Periodically reevaluate the long-term use and adjust dosage as needed.

Checks and decisions your prescriber makes 1 step

Your prescriber follows these steps. Ask them about any you don’t understand.

  • Screen patients for a personal or family history of suicide, bipolar disorder, and depression prior to initiating treatment.

ADHD stands for attention-deficit hyperactivity disorder.

People with severe kidney problems (eGFR < 30 mL/min/1.73m 2)

Starting dose 100 mg once daily Highest dose 200 mg a day
  • Dosage may be titrated in weekly increments of 50 to 100 mg once daily

Good to know

No dosage adjustment is recommended in patients with mild to moderate (eGFR of 30 to 89 mL/min/1.73m 2) renal impairment. Administer orally with or without food. Do not cut, crush, or chew the capsules. Swallow capsules whole, or open the capsule and sprinkle the entire contents over a teaspoonful or tablespoonful of pudding or applesauce. Consume the food mixture in its entirety, without chewing, within 15 minutes for pudding, or within 2 hours for applesauce; do not store for future use.

eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.

See the Full Dosing Instructions on DailyMed →

Side Effects

Common side effects of Qelbree include:

Common side effects

  • Sleepiness
  • Tiredness or fatigue
  • Decreased appetite
  • Nausea or vomiting
  • Trouble sleeping (insomnia)
  • Irritability (more common in children)
  • Headache (more common in adults)
  • Dry mouth and constipation (more common in adults)

When to get medical help

  • Call your doctor right away for new or sudden changes in mood, behavior, thoughts or feelings, including thoughts about suicide or dying.
  • Get emergency help for a suicide attempt or acting on dangerous impulses.
  • Tell your doctor about new or worse depression, anxiety, panic attacks, agitation, restlessness, aggression or irritability.
  • Report signs of mania, such as greatly increased energy, racing thoughts, reckless behavior or severe trouble sleeping.
  • Report a racing heartbeat or a rise in blood pressure.
  • Call poison control at 1-800-222-1222 or go to an emergency room after an overdose.

Warnings and Precautions

Qelbree carries a boxed warning for suicidal thoughts and behaviors. In clinical trials, higher rates of suicidal thoughts and behavior were reported in patients treated with Qelbree than in patients treated with placebo. All Qelbree-treated patients should be closely monitored for worsening and for new suicidal thoughts or behaviors.

  • Blood pressure and heart rate can rise, so they should be checked before starting, after dose increases and periodically.
  • It may trigger manic episodes in people with bipolar disorder.
  • It can cause sleepiness and fatigue, so be careful driving.
  • It may affect weight.

Interactions

Several medicines can cause problems with Qelbree.

  • MAOIs: risk of dangerous high blood pressure, so never use together or within 14 days.
  • Alosetron, duloxetine, ramelteon, tasimelteon, tizanidine and theophylline: viloxazine strongly blocks CYP1A2, so these can build up.
  • CYP2D6 and CYP3A4 substrates: viloxazine can raise their levels, so doses may need adjusting.

Interactions Listed in the FDA-Approved Label

From the Viloxazine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Monoamine Oxidase Inhibitors (MAOI)
    What happensConcomitant use of Qelbree with an MAOI may lead to a potentially life-threatening hypertensive crisis.
    What to doConcomitant use of Qelbree with an MAOI or within 2 weeks after discontinuing an MAOI is contraindicated.
  • Sensitive CYP1A2 substrates or CYP1A2 substrates with a narrow therapeutic range
    What happensViloxazine is a strong CYP1A2 inhibitor. Concomitant use of viloxazine significantly increases the total exposure, but not peak exposure, of sensitive CYP1A2 substrates, which may increase the risk of adverse reactions associated with these CYP1A2 substrates.
    What to doCoadministration with Qelbree is contraindicated.
  • Moderate sensitive CYP1A2 substrates
    What happensViloxazine is a strong CYP1A2 inhibitor. Concomitant use of viloxazine significantly increases the total, but not peak, exposure of sensitive CYP1A2 substrates, which may increase the risk of adverse reactions associated with these CYP1A2 substrates.
    What to doNot recommended for coadministration with Qelbree. Dose reduction may be warranted if coadministered.
  • CYP2D6 substrates
    What happensViloxazine is a weak inhibitor of CYP2D6, and increases the exposure of CYP2D6 substrates when coadministered.
    What to doMonitor patients for adverse reactions and adjust dosages of CYP2D6 substrates, as clinically indicated.
  • CYP3A4 substrates
    What happensViloxazine is a weak inhibitor of CYP3A4 which increases the exposure of CYP3A4 substrates when coadministered.
    What to doMonitor patients for adverse reactions and adjust dosages of CYP3A4 substrates, as clinically indicated.
Read the label’s full interactions text

7 DRUG INTERACTIONS Moderate sensitive CYP1A2 substrates: Not recommended for coadministration with Qelbree. Dose reduction may be warranted 7.1 Drugs Having Clinically Important Interactions with Qelbree Table 3: Clinically Important Drug Interactions with Qelbree Monoamine Oxidase Inhibitors (MAOI) Clinical Impact Concomitant use of Qelbree with an MAOI may lead to a potentially life-threatening hypertensive crisis. Intervention Concomitant use of Qelbree with an MAOI or within 2 weeks after discontinuing an MAOI is contraindicated. Sensitive CYP1A2 Substrates or CYP1A2 Substrates with a Narrow Therapeutic Range Clinical Impact Viloxazine is a strong CYP1A2 inhibitor. Concomitant use of viloxazine significantly increases the total exposure, but not peak exposure, of sensitive CYP1A2 substrates, which may increase the risk of adverse reactions associated with these CYP1A2 substrates. Intervention Coadministration with Qelbree is contraindicated. Moderate Sensitive CYP1A2 Substrate Clinical Impact Viloxazine is a strong CYP1A2 inhibitor. Concomitant use of viloxazine significantly increases the total, but not peak, exposure of sensitive CYP1A2 substrates, which may increase the risk of adverse reactions associated with these CYP1A2 substrates. Intervention Not recommended for coadministration with Qelbree. Dose reduction may be warranted if coadministered. CYP2D6 Substrates Clinical Impact Viloxazine is a weak inhibitor of CYP2D6, and increases the exposure of CYP2D6 substrates when coadministered. Intervention Monitor patients for adverse reactions and adjust dosages of CYP2D6 substrates, as clinically indicated.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Tell your doctor about a personal or family history of suicide, bipolar disorder, depression, mania or hypomania.
  • Tell your doctor about blood pressure or heart rate problems.
  • Severe kidney problems: a lower dose is recommended.
  • Pregnancy: Qelbree may cause maternal harm and was harmful to offspring in animal studies. Tell your doctor right away if you become pregnant. Your doctor may stop it unless the benefit outweighs the risk.
  • Breastfeeding: Qelbree passes into breast milk at low levels. Talk with your doctor about feeding your baby.
  • Not established in children younger than 6.
  • Older adults: too few people 65 and older were studied to know.

Overdose

In reports with immediate-release viloxazine, overdose caused mostly drowsiness, and sometimes impaired consciousness, diminished reflexes and a faster heart rate. There is no specific antidote. Call poison control at 1-800-222-1222 or go to an emergency room right away.

Half-Life and How Your Body Processes It

Qelbree reaches peak blood levels in about 5 hours. A high-fat meal or sprinkling on applesauce changes absorption only slightly. Viloxazine's half-life is about 7 hours, and steady levels are reached after two days of once-daily use. It is broken down mainly by CYP2D6 and UGT enzymes and cleared mostly through the kidneys in urine. Children's blood levels were higher than adults'.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Viloxazine: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Viloxazine — the kind of thing our pharmacy team would talk through with you at the counter.

What is Qelbree (viloxazine) used for?

It treats ADHD in adults and children 6 years and older. It is a non-stimulant that is thought to work by raising norepinephrine in the brain.

How do I take Qelbree?

Take it once a day, with or without food. Swallow the capsule whole, or open it and sprinkle all of it on applesauce or pudding and swallow without chewing. Use the pudding mixture within 15 minutes and the applesauce mixture within 2 hours. Don't cut, crush or chew the capsule.

What happens if I miss a dose of Qelbree?

Ask your prescriber or pharmacist what to do, since the right approach depends on your situation. Don't take extra on your own.

Can Qelbree make me sleepy or affect driving?

Yes, sleepiness and tiredness are common. Don't drive or use hazardous machinery until you know how it affects you.

What side effects should I call my doctor about?

Call right away for new or worse mood changes, depression, anxiety, agitation, aggression, suicidal thoughts, or signs of mania. Also report a fast heartbeat or high blood pressure. Keep follow-up visits, especially in the first few months and after dose changes.

Is Qelbree safe in pregnancy or while breastfeeding?

Qelbree may cause harm to the mother during pregnancy, and animal studies showed harm to offspring. Tell your doctor right away if you become pregnant. It passes into breast milk in low amounts, so talk with your doctor about the best way to feed your baby.

Is viloxazine available over the counter?

No. Viloxazine is a prescription medicine: every viloxazine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was viloxazine first available?

The earliest FDA record we hold for viloxazine is from 2020: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when viloxazine was first used.

What is the brand name of viloxazine?

Viloxazine is the generic name. Its brand name is Qelbree.

What is the generic name of Qelbree?

The generic name of Qelbree is viloxazine. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is viloxazine?

Viloxazine belongs to the drug class Norepinephrine Reuptake Inhibitor, its established pharmacologic class on the FDA label. The FDA also groups it by how it works: Norepinephrine Uptake Inhibitor, CYP2D6 Enzyme Inhibitor and CYP1A2 Enzyme Inhibitor.

What strengths does viloxazine come in?

Viloxazine is listed in the FDA's National Drug Code Directory in these forms and strengths. Extended-release capsule (by mouth): 100 mg, 150 mg and 200 mg. A listing does not mean every pharmacy stocks every strength.

How much does viloxazine cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $12.73 per extended-release capsule of brand-name Qelbree across 3 strengths as of November 11, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a viloxazine shortage?

No. Viloxazine is not on the FDA's drug shortage list as of Nov 18, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the viloxazine prescribing information (package insert)?

The full FDA-approved prescribing information for viloxazine, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Supernus Pharmaceuticals, Inc's, revised Oct 5, 2026, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Viloxazine

Skip the scrolling. Ask in your own words and get an answer from Viloxazine’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Viloxazine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Viloxazine on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Viloxazine Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Viloxazine Forms and Strengths (How It Comes)

Viloxazine comes in 1 dose form, the extended-release capsule. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Viloxazine inactive ingredients by manufacturer.

Extended-release capsule

By mouth
Brands Qelbree (2021)
How this form is used
What it may be used for
  • Qelbree is used to treat ADHD in adults and children 6 years and older.
Important instructions
  • Qelbree is taken by mouth once a day, with or without food.
  • Swallow Qelbree capsules whole. Do not cut, crush or chew them.
  • If needed, open the Qelbree capsule and sprinkle all the contents on applesauce or pudding.
  • Take the Qelbree food mixture within 2 hours for applesauce or 15 minutes for pudding, and do not store it.
Available strengths 3 strengths
3 FDA-listed product records ⓘ

Viloxazine on the U.S. Market: Products, Makers and Brands

How Viloxazine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 3 Viloxazine product records with the FDA, mostly as extended-release capsule; the earliest marketing or approval year on record is 2020. The one brand name in the directory today is Qelbree; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
3
FDA-listed product records ⓘ
2020
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (12) · Unfinished capsule, extended release (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

How Widely Viloxazine Is Used (Medicaid Data)

How many Viloxazine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

451,086
Medicaid prescriptions filled (Q1–Q4 2025)
$226.6M paid by Medicaid, before rebates

How commonly is Viloxazine prescribed? Of the 1,666 medications we measure, Viloxazine ranks #277 by Medicaid prescriptions — more than 83% of them.

Where Viloxazine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Viloxazine product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 200 mg 24 hr extended release oral capsule is the most-dispensed Viloxazine product — about 59% of these Medicaid prescriptions.

24 HR viloxazine 200 MG Extended Release Oral Capsule Most dispensed

264,387 Medicaid prescriptions (Q1–Q4 2025) 59% of Viloxazine prescriptions shown $138.5M paid by Medicaid, before rebates ≈ $524 per prescription, before rebates

2 of 6 listed NDCs had Medicaid claims. RxNorm 2536756

24 HR viloxazine 100 MG Extended Release Oral Capsule

113,838 Medicaid prescriptions (Q1–Q4 2025) 25% of Viloxazine prescriptions shown $46.5M paid by Medicaid, before rebates ≈ $408 per prescription, before rebates

1 of 6 listed NDCs had Medicaid claims. RxNorm 2536548

24 HR viloxazine 150 MG Extended Release Oral Capsule

72,861 Medicaid prescriptions (Q1–Q4 2025) 16% of Viloxazine prescriptions shown $41.6M paid by Medicaid, before rebates ≈ $572 per prescription, before rebates

1 of 6 listed NDCs had Medicaid claims. RxNorm 2536750

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 4 of the 18 listed Viloxazine NDCs had Medicaid claims.

Compare Viloxazine Products

A representative set of FDA-listed product records for Viloxazine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Extended-release capsule
100 mg Oral Supernus Pharmaceuticals, Inc NDA View NDC →
150 mg Oral Supernus Pharmaceuticals, Inc NDA View NDC →
200 mg Oral Supernus Pharmaceuticals, Inc NDA View NDC →

Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Viloxazine NDCs →

Viloxazine Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Viloxazine recalls since July 2021.

✅No Viloxazine recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 12, 2026.

Viloxazine in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
1
Strengths
3
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Ingredient (IN) Viloxazine RxCUI 11196
  1. Dose form (SCDF) Extended Release Oral Capsule RxCUI 2536547
    In current FDA listings
    Its 3 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Viloxazine Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Viloxazine: the national average from CMS’s weekly NADAC survey, as of Nov 11, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Oct 2023.

Strength

For brand-name Qelbree, the 100 mg extended-release capsule, pharmacies paid an average of $12.73 per capsule as of Nov 11, 2026, up 5.9% from $12.02 a year earlier.

What pharmacies pay now
$12.73
per capsule, as of Nov 11, 2026
Last 4 weeks
No change
from $12.73 on Oct 14, 2026
Last 12 months
Up 5.9%
from $12.02 on Nov 12, 2025
Lowest and highest since Oct 2023
$10.70 to $12.75
per capsule

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Qelbree 100 mg extended-release capsule: the average pharmacy price per capsule, the last survey of each month
MonthPharmacy price
Nov 2026$12.73
Oct 2026$12.73
Sep 2026$12.73
Aug 2026$12.73
Jul 2026$12.73
Jun 2026$12.75
May 2026$12.75
Apr 2026$12.74
Mar 2026$12.74
Feb 2026$12.74
Jan 2026$12.74
Dec 2025$12.02
Nov 2025$12.02
Oct 2025$12.02
Sep 2025$12.04
Aug 2025$12.04
Jul 2025$12.04
Jun 2025$12.04
May 2025$12.04
Apr 2025$12.06
Mar 2025$12.06
Feb 2025$12.06
Jan 2025$12.06
Dec 2024$11.38
Nov 2024$11.37
Oct 2024$11.38
Sep 2024$11.38
Aug 2024$11.39
Jul 2024$11.39
Jun 2024$11.38
May 2024$11.38
Apr 2024$11.35
Mar 2024$11.35
Feb 2024$11.35
Jan 2024$11.35
Dec 2023$10.70
Nov 2023$10.70
Oct 2023$10.70
FormStrengthVersion What pharmacies pay
Extended-release capsule · Oral 100 mg Qelbree (brand) $12.73 per capsule NDC details & price history
Extended-release capsule · Oral 150 mg Qelbree (brand) $12.73 per capsule NDC details & price history
Extended-release capsule · Oral 200 mg Qelbree (brand) $12.73 per capsule NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Viloxazine Brand Names

Viloxazine has one brand name on record: Qelbree. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Qelbree 2021

Who Makes Viloxazine: Manufacturers and Labelers

One company lists Viloxazine products with the FDA. By number of product records, the largest are Supernus Pharmaceuticals, Inc. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Supernus Pharmaceuticals, Inc 3

Sources for This Viloxazine Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Oct 5, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Viloxazine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
3
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Supernus Pharmaceuticals, Inc
Linked label effective
Oct 5, 2026
Composite sections available
13
Linked SPL Set ID
aedf408d-0f84-418d-9416-7c39ddb0d29a
Linked SPL Document ID
5d1a1304-82b6-0e9c-e063-6294a90a8846
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Supernus Pharmaceuticals, Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →